Literature DB >> 1285500

Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-alpha in the rat.

J L Wright1, R E Merchant.   

Abstract

Human recombinant tumor necrosis factor-alpha (rTNF-alpha) was administered to normal Fischer 344 rats by stereotaxic intracerebral (IC) injection. Animals received a single injection of either 6 x 10(4) U rTNF-alpha or excipient in their right parietal lobe. Others received three consecutive daily injections of either 6 x 10(4) U rTNF-alpha or excipient to examine effects of higher accumulative doses. Histological examination of the brain revealed that both single and multiple IC injections of rTNF-alpha triggered an immigration of circulating leukocytes into the site of TNF-alpha injection. After one injection, this cell population was composed mainly of macrophages and neutrophils. Maximal leukocytic influx occurred by 48 h and was composed mostly of neutrophils which were limited to the injection site and perivascular space. Quantitation of the inflammatory reaction by measurement of tissue myeloperoxidase levels supported these histological observations. One day after multiple rTNF-alpha injections, leukocytic adhesion to endothelium, vascular cuffing and leukocytic infiltration into the neuropil was observed at levels comparable to those seen 3 days following a single rTNF-alpha injection. We conclude that while one or more IC injection(s) of 6 x 10(4) U rTNF-alpha was well tolerated in normal rats, at this dose the cytokine triggers a pronounced leukocytic infiltration at the site of injection. These results support a role for TNF-alpha as a mediator in inflammatory responses within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1285500     DOI: 10.1007/bf00304638

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  37 in total

1.  Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factors-alpha and -beta: comparison to recombinant interferon-gamma and interleukin-1 alpha.

Authors:  I S Figari; N A Mori; M A Palladino
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

Review 2.  Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data.

Authors:  G E Grau; P F Piguet; P Vassalli; P H Lambert
Journal:  Immunol Rev       Date:  1989-12       Impact factor: 12.988

3.  In vivo neutrophil emigration in response to interleukin-1 and tumor necrosis factor-alpha.

Authors:  M J Mason; D E Van Epps
Journal:  J Leukoc Biol       Date:  1989-01       Impact factor: 4.962

4.  Hypothalamic action of cachectin to alter pituitary hormone release.

Authors:  V Rettori; L Milenkovic; B A Beutler; S M McCann
Journal:  Brain Res Bull       Date:  1989-12       Impact factor: 4.077

5.  Systemic treatment with murine recombinant interleukin-1 beta inhibits the growth and progression of malignant glioma in the rat.

Authors:  C D Rice; R E Merchant
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

6.  Characteristics of fever and acute-phase response induced in rabbits by IL-1 and TNF.

Authors:  A Morimoto; Y Sakata; T Watanabe; N Murakami
Journal:  Am J Physiol       Date:  1989-01

7.  An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism.

Authors:  T H Pohlman; K A Stanness; P G Beatty; H D Ochs; J M Harlan
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

8.  In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes.

Authors:  I Colditz; R Zwahlen; B Dewald; M Baggiolini
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

9.  The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis.

Authors:  K Saukkonen; S Sande; C Cioffe; S Wolpe; B Sherry; A Cerami; E Tuomanen
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

10.  Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.

Authors:  A Waage; A Halstensen; R Shalaby; P Brandtzaeg; P Kierulf; T Espevik
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  5 in total

1.  Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes.

Authors:  N G Baldwin; C D Rice; T M Tuttle; H D Bear; J I Hirsch; R E Merchant
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

2.  Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat.

Authors:  J L Wright; R E Merchant
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

3.  Opposing actions of hippocampus TNFα receptors on limbic seizure susceptibility.

Authors:  Marc S Weinberg; Bonita L Blake; Thomas J McCown
Journal:  Exp Neurol       Date:  2013-01-16       Impact factor: 5.330

4.  Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension.

Authors:  Gavin Wright; Debbie Shawcross; Steven W M Olde Damink; Rajiv Jalan
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 5.  Inflaming the brain: CRPS a model disease to understand neuroimmune interactions in chronic pain.

Authors:  C Linnman; L Becerra; D Borsook
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-29       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.